Anli Zhang

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 5

Top Topics

Dendritic Cells

Tyrosine Kinase

Advanced Non Small Cell Lung Cancer

Top Venues

Nature communications

Science translational medicine

Nature immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Anli Zhang, Zhenhua Ren, Kuo-Fu Tseng, Xiaojuan Liu, Huiyu Li, Changzheng Lu, Yueqi Cai, John D Minna, Yang-Xin Fu
Dual targeting of CTLA-4 and CD47 on Treg cells promotes immunity against solid tumors. Science translational medicine 13 (605) (2021)
Lang Rao, Lei Wu, Zhida Liu, Rui Tian, Guocan Yu, Zijian Zhou, Kuikun Yang, Hong-Gang Xiong, Anli Zhang, Guang-Tao Yu, Wenjing Sun, Han Xu, Jingya Guo, Andrew Li, Hongmin Chen, Zhi-Jun Sun, Yang-Xin Fu, Xiaoyuan Shawn Chen
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis. Nature communications 11 (1) (2020)
Chuanhui Han, Zhida Liu, Yunjia Zhang, Aijun Shen, Chunbo Dong, Anli Zhang, Casey Timmerman, Zhenhua Ren, Changzheng Lu, Xuezhi Cao, Chun-Li Zhang, Jian Qiao, Yang-Xin Fu
Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling. Nature immunology 21 (5) (2020)
Chuanhui Han, Anli Zhang, Zhida Liu, Casey Moore, Yang-Xin Fu
Small molecular drugs reshape tumor microenvironment to synergize with immunotherapy. Oncogene 40 (5) (2020)
Zhida Liu, Chuanhui Han, Chunbo Dong, Aijun Shen, Eric J Hsu, Zhenhua Ren, Changzheng Lu, Longchao Liu, Anli Zhang, Casey Timmerman, Yang Pu, Yang Wang, Mingyi Chen, Jian Qiao, Yang-Xin Fu
Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity. Science immunology 4 (38) (2020)